Published in Immun Ageing on February 02, 2010
Viral infection and aging as cofactors for the development of pulmonary fibrosis. Expert Rev Respir Med (2010) 0.99
Pulmonary fibrosis induced by γ-herpesvirus in aged mice is associated with increased fibroblast responsiveness to transforming growth factor-β. J Gerontol A Biol Sci Med Sci (2011) 0.94
Mechanisms of immunosenescence: lessons from models of accelerated immune aging. Ann N Y Acad Sci (2012) 0.93
T-Cell Immunity to Influenza in Older Adults: A Pathophysiological Framework for Development of More Effective Vaccines. Front Immunol (2016) 0.81
Importance of antibody in virus infection and vaccine-mediated protection by a latency-deficient recombinant murine γ-herpesvirus-68. J Immunol (2011) 0.77
Immune aging and challenges for immune protection of the graying population. Aging Dis (2011) 0.75
Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science (2003) 10.22
Immunological memory and protective immunity: understanding their relation. Science (1996) 10.02
Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol (1997) 7.71
Duration of antiviral immunity after smallpox vaccination. Nat Med (2003) 7.39
Humoral immunity due to long-lived plasma cells. Immunity (1998) 6.35
Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells. J Exp Med (1996) 6.08
Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol (2003) 5.51
Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J Gen Virol (1992) 5.42
The aging immune system: primer and prospectus. Science (1996) 4.86
Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine gammaherpesvirus 68. J Virol (1996) 4.02
Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages. J Immunol (2000) 3.51
Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature (2008) 3.47
Pathogenesis of murine gammaherpesvirus infection in mice deficient in CD4 and CD8 T cells. J Virol (1993) 2.93
THE IMMUNOGLOBULINS OF MICE. V. THE METABOLIC (CATABOLIC) PROPERTIES OF FIVE IMMUNOGLOBULIN CLASSES. J Exp Med (1965) 2.91
B cells regulate murine gammaherpesvirus 68 latency. J Virol (1999) 2.79
The half-lives of serum immunoglobulins in adult mice. Eur J Immunol (1988) 2.73
Natural history of murine gamma-herpesvirus infection. Philos Trans R Soc Lond B Biol Sci (2001) 2.50
Differential contributions of central and effector memory T cells to recall responses. J Exp Med (2005) 2.40
Natural and vaccine-related immunity to Streptococcus pneumoniae. J Infect Dis (1986) 2.34
Interleukin 2, but not other common gamma chain-binding cytokines, can reverse the defect in generation of CD4 effector T cells from naive T cells of aged mice. J Exp Med (1999) 2.33
Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med (1993) 2.27
Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients. Clin Cancer Res (2007) 2.25
Four distinct patterns of memory CD8 T cell responses to chronic murine cytomegalovirus infection. J Immunol (2006) 2.25
Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression. Hum Pathol (1994) 2.23
Murine gammaherpesvirus M2 gene is latency-associated and its protein a target for CD8(+) T lymphocytes. Proc Natl Acad Sci U S A (1999) 2.19
Immunological studies of aging. II. Loss of IgG and high avidity plaque-forming cells and increased suppressor cell activity in aging mice. J Exp Med (1976) 2.18
Antigen-independent changes in naive CD4 T cells with aging. J Exp Med (1996) 2.14
Expression of the open reading frame 74 (G-protein-coupled receptor) gene of Kaposi's sarcoma (KS)-associated herpesvirus: implications for KS pathogenesis. J Virol (1999) 2.07
Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients. Am J Surg Pathol (2003) 2.06
Immunosenescence and germinal center reaction. Immunol Rev (1997) 2.00
Chronic herpesvirus reactivation occurs in aging. Exp Gerontol (2007) 1.99
The post-transplant lymphoproliferative disorder-a literature review. Pediatr Nephrol (2004) 1.92
Requirements for CD8 T-cell priming, memory generation and maintenance. Curr Opin Immunol (2007) 1.91
Dissecting the host response to a gamma-herpesvirus. Philos Trans R Soc Lond B Biol Sci (2001) 1.89
Developing and maintaining protective CD8+ memory T cells. Immunol Rev (2006) 1.82
Kinetic analysis of the specific host response to a murine gammaherpesvirus. J Virol (1998) 1.82
Why aging T cells fail: implications for vaccination. Immunity (2006) 1.78
Long-term humoral immunity against viruses: revisiting the issue of plasma cell longevity. Trends Microbiol (1996) 1.76
Immune control of the number and reactivation phenotype of cells latently infected with a gammaherpesvirus. J Virol (2002) 1.74
Immunodominance of major histocompatibility complex class I-restricted influenza virus epitopes can be influenced by the T-cell receptor repertoire. J Virol (1995) 1.71
Defective generation but normal maintenance of memory T cells in old mice. Eur J Immunol (2002) 1.64
Analysis of the virus-specific and nonspecific B cell response to a persistent B-lymphotropic gammaherpesvirus. J Immunol (2000) 1.64
Control of gammaherpesvirus latency by latent antigen-specific CD8(+) T cells. J Exp Med (2000) 1.61
Antibody-mediated control of persistent gamma-herpesvirus infection. J Immunol (2002) 1.59
Failure to respond to influenza vaccine in the aged: correlation with B-cell number and function. J Lab Clin Med (1978) 1.57
Respiratory virus infection of mice provokes a permanent humoral immune response. J Virol (1994) 1.55
Expansion of protective CD8+ T-cell responses driven by recombinant cytomegaloviruses. J Virol (2004) 1.55
Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice. J Virol (2002) 1.48
Latent antigen vaccination in a model gammaherpesvirus infection. J Virol (2001) 1.45
Epstein-Barr virus-associated lymphoproliferative disease during methotrexate therapy for psoriasis. Arch Dermatol (1997) 1.43
Response of aged mice to primary virus infections. Immunol Rev (2005) 1.40
Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders: special references to lymphomas surrounding this newly recognized clinicopathologic disease. Cancer Sci (2008) 1.36
Kaposi's sarcoma-associated herpesvirus: epidemiology, virology, and molecular biology. Adv Virus Res (1999) 1.35
The effect of age on the cognate function of CD4+ T cells. Immunol Rev (2005) 1.32
From naive to effector--alterations with aging. Immunol Rev (1997) 1.32
Memory generation and maintenance of CD8+ T cell function during viral persistence. J Immunol (2007) 1.23
Epstein-Barr virus: the first human tumor virus and its role in cancer. Proc Assoc Am Physicians (2000) 1.22
Ig VH hypermutation is absent in the germinal centers of aged mice. J Immunol (1995) 1.22
Alterations in the human immune response to the hepatitis B vaccine among the elderly. Cell Immunol (1987) 1.17
An age-related increase in the number of CD8+ T cells carrying receptors for an immunodominant Epstein-Barr virus (EBV) epitope is counteracted by a decreased frequency of their antigen-specific responsiveness. Mech Ageing Dev (2003) 1.17
Antigen-specific CD8+ T cell clonal expansions develop from memory T cell pools established by acute respiratory virus infections. J Immunol (2007) 1.10
Antibody-forming cell induction during an early phase of germinal centre development and its delay with ageing. Immunology (1989) 1.09
Early establishment of gamma-herpesvirus latency: implications for immune control. J Immunol (2005) 1.09
The physiology of germinal centers. Crit Rev Immunol (1996) 1.08
Immunity and ageing in man: Annual Review 2006/2007. Exp Gerontol (2007) 1.07
Immunosenescence: a problem of lymphopoiesis, homeostasis, microenvironment, and signaling. Immunol Rev (2005) 1.04
The defects in effector generation associated with aging can be reversed by addition of IL-2 but not other related gamma(c)-receptor binding cytokines. Vaccine (2000) 1.03
Murine gamma-herpesvirus-68: a mouse model for infectious mononucleosis? Mol Med Today (2000) 1.02
Immunological memory to viral infection. Curr Opin Immunol (2004) 1.02
Changes in Epstein-Barr virus antibody titers associated with aging. Proc Soc Exp Biol Med (1985) 1.00
Endogenous reactivation of Epstein-Barr virus infections. J Infect Dis (1977) 0.97
Reduced levels of neutralizing antibodies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma. J Infect Dis (2004) 0.96
The repertoire diversity and magnitude of antibody responses to bacterial antigens in aged mice: I. Age-associated changes in antibody responses differ according to the mouse strain. Cell Immunol (1991) 0.95
Aging and immune function. Summary of a workshop held at Trudeau Institute, Saranac Lake, NY. Mech Ageing Dev (2005) 0.94
Catabolism of homologous murine monoclonal hybridoma IgG antibodies in mice. Immunology (1987) 0.94
A gamma-herpesvirus deficient in replication establishes chronic infection in vivo and is impervious to restriction by adaptive immune cells. Virology (2006) 0.94
A study of autologous anti-idiotypic antibody-forming cells in mice of different ages and genetic backgrounds. Cell Immunol (1992) 0.93
Epidemiologic studies assessing the role of the Epstein-Barr virus in Hodgkin's disease. Yale J Biol Med (1987) 0.91
Varicella: historical perspective and clinical overview. J Infect Dis (1996) 0.88
Infection of dendritic cells by a gamma2-herpesvirus induces functional modulation. J Immunol (2005) 0.88
Persistent gamma-herpesvirus infections: what can we learn from an experimental mouse model? J Exp Med (2002) 0.87
Perturbation of B cell activation in SLAM-associated protein-deficient mice is associated with changes in gammaherpesvirus latency reservoirs. J Immunol (2007) 0.86
Immune regulation of viral infection and vice versa. Immunol Res (2005) 0.86
Plasmacytic hyperplasia in age-related Epstein-Barr virus-associated lymphoproliferative disorders: a report of two cases. Pathol Res Pract (2008) 0.79
The serological signs of the Epstein-Barr virus (EBV) activity in the elderly. Acta Microbiol Immunol Hung (1997) 0.76
Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat Med (2004) 5.22
Activated primary and memory CD8 T cells migrate to nonlymphoid tissues regardless of site of activation or tissue of origin. J Immunol (2004) 3.15
Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus. J Exp Med (2008) 3.15
Novel substituted (Z)-2-(N-benzylindol-3-ylmethylene)quinuclidin-3-one and (Z)-(+/-)-2-(N-benzylindol-3-ylmethylene)quinuclidin-3-ol derivatives as potent thermal sensitizing agents. Bioorg Med Chem Lett (2007) 3.14
Activation phenotype, rather than central- or effector-memory phenotype, predicts the recall efficacy of memory CD8+ T cells. J Exp Med (2007) 3.09
NADPH oxidase activity is essential for Keap1/Nrf2-mediated induction of GCLC in response to 2-indol-3-yl-methylenequinuclidin-3-ols. Cancer Res (2003) 3.02
Type I interferons regulate cytolytic activity of memory CD8(+) T cells in the lung airways during respiratory virus challenge. Immunity (2010) 2.52
Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression. J Clin Invest (2007) 2.52
Immunity to respiratory viruses. Annu Rev Immunol (2009) 2.50
Differential contributions of central and effector memory T cells to recall responses. J Exp Med (2005) 2.40
Specific patterns of electrophile adduction trigger Keap1 ubiquitination and Nrf2 activation. J Biol Chem (2005) 2.37
Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane. Chem Res Toxicol (2005) 2.22
Gamma-herpesvirus latency is preferentially maintained in splenic germinal center and memory B cells. J Exp Med (2002) 2.20
Memory T cell populations in the lung airways are maintained by continual recruitment. J Immunol (2006) 2.17
The chemokine receptor CCR5 plays a key role in the early memory CD8+ T cell response to respiratory virus infections. Immunity (2008) 2.13
ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes. Proc Natl Acad Sci U S A (2008) 2.10
Differential antigen presentation regulates the changing patterns of CD8+ T cell immunodominance in primary and secondary influenza virus infections. J Exp Med (2003) 2.07
Nonspecific recruitment of memory CD8+ T cells to the lung airways during respiratory virus infections. J Immunol (2003) 2.01
Lymphocyte activation gene-3 (CD223) regulates the size of the expanding T cell population following antigen activation in vivo. J Immunol (2004) 2.00
T-cell memory and recall responses to respiratory virus infections. Immunol Rev (2006) 1.95
Cutting edge: effector memory CD8+ T cells play a prominent role in recall responses to secondary viral infection in the lung. J Immunol (2004) 1.90
Distinct functions of antigen-specific CD4 T cells during murine Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A (2010) 1.85
Persistence and turnover of antigen-specific CD4 T cells during chronic tuberculosis infection in the mouse. J Immunol (2003) 1.84
Priming with cold-adapted influenza A does not prevent infection but elicits long-lived protection against supralethal challenge with heterosubtypic virus. J Immunol (2007) 1.78
Age-related retinopathy in NRF2-deficient mice. PLoS One (2011) 1.71
Novel n-3 fatty acid oxidation products activate Nrf2 by destabilizing the association between Keap1 and Cullin3. J Biol Chem (2006) 1.70
NADPH oxidase limits innate immune responses in the lungs in mice. PLoS One (2010) 1.69
Nrf2 degradation by the ubiquitin proteasome pathway is inhibited by KIAA0132, the human homolog to INrf2. Oncogene (2002) 1.65
Antibody-mediated control of persistent gamma-herpesvirus infection. J Immunol (2002) 1.59
T-cell immunosenescence: lessons learned from mouse models of aging. Trends Immunol (2009) 1.55
CXCR3 directs antigen-specific effector CD4+ T cell migration to the lung during parainfluenza virus infection. J Immunol (2009) 1.53
Clonal expansions and loss of receptor diversity in the naive CD8 T cell repertoire of aged mice. J Immunol (2009) 1.53
Increased expression of nuclear factor E2 p45-related factor 2 (NRF2) in head and neck squamous cell carcinomas. Head Neck (2006) 1.52
Covalent modification at Cys151 dissociates the electrophile sensor Keap1 from the ubiquitin ligase CUL3. Chem Res Toxicol (2008) 1.47
Cutting edge: Antigen is not required for the activation and maintenance of virus-specific memory CD8+ T cells in the lung airways. J Immunol (2007) 1.46
IL-15 regulates both quantitative and qualitative features of the memory CD8 T cell pool. J Immunol (2009) 1.45
Immunity and retroviral superantigens in humans. Trends Immunol (2002) 1.44
Long-term maintenance of virus-specific effector memory CD8+ T cells in the lung airways depends on proliferation. J Immunol (2002) 1.42
Inflammatory chemokine receptors regulate CD8(+) T cell contraction and memory generation following infection. J Exp Med (2011) 1.40
Early dysregulation of the memory CD8+ T cell repertoire leads to compromised immune responses to secondary viral infection in the aged. Immun Ageing (2012) 1.39
In a murine tuberculosis model, the absence of homeostatic chemokines delays granuloma formation and protective immunity. J Immunol (2009) 1.38
Cutting edge: T-bet and IL-27R are critical for in vivo IFN-gamma production by CD8 T cells during infection. J Immunol (2008) 1.36
Identification of protective and non-protective T cell epitopes in influenza. Vaccine (2005) 1.35
Cutting edge: effector memory CD8+ T cells in the lung airways retain the potential to mediate recall responses. J Immunol (2003) 1.34
Novel chemical enhancers of heat shock increase thermal radiosensitization through a mitotic catastrophe pathway. Cancer Res (2007) 1.32
Molecular mechanism of human Nrf2 activation and degradation: role of sequential phosphorylation by protein kinase CK2. Free Radic Biol Med (2007) 1.31
Uneven distribution of MHC class II epitopes within the influenza virus. Vaccine (2005) 1.31
Differential gamma-herpesvirus distribution in distinct anatomical locations and cell subsets during persistent infection in mice. J Immunol (2003) 1.30
Lymphotoxin-alpha-deficient mice make delayed, but effective, T and B cell responses to influenza. J Immunol (2002) 1.29
Early T-cell responses in tuberculosis immunity. Immunol Rev (2008) 1.28
Cutting edge: virus-specific CD4+ memory T cells in nonlymphoid tissues express a highly activated phenotype. J Immunol (2002) 1.28
Smad3-ATF3 signaling mediates TGF-beta suppression of genes encoding Phase II detoxifying proteins. Free Radic Biol Med (2005) 1.25
A mouse model for infectious mononucleosis. Immunol Res (2002) 1.24
The route of priming influences the ability of respiratory virus-specific memory CD8+ T cells to be activated by residual antigen. J Exp Med (2010) 1.24
The functional heterogeneity of type 1 effector T cells in response to infection is related to the potential for IFN-gamma production. J Immunol (2005) 1.23
Vaccination with an acidic polymerase epitope of influenza virus elicits a potent antiviral T cell response but delayed clearance of an influenza virus challenge. J Immunol (2005) 1.23
The majority of immunogenic epitopes generate CD4+ T cells that are dependent on MHC class II-bound peptide-flanking residues. J Immunol (2002) 1.22
Early CD4(+) T cell help prevents partial CD8(+) T cell exhaustion and promotes maintenance of Herpes Simplex Virus 1 latency. J Immunol (2009) 1.20
gamma-Herpesvirus-induced protection against bacterial infection is transient. Viral Immunol (2009) 1.19
Novel substituted (Z)-5-((N-benzyl-1H-indol-3-yl)methylene)imidazolidine-2,4-diones and 5-((N-benzyl-1H-indol-3-yl)methylene)pyrimidine-2,4,6(1H,3H,5H)-triones as potent radio-sensitizing agents. Bioorg Med Chem Lett (2009) 1.19
IgM production by bone marrow plasmablasts contributes to long-term protection against intracellular bacterial infection. J Immunol (2010) 1.18
Cysteine-based regulation of the CUL3 adaptor protein Keap1. Toxicol Appl Pharmacol (2009) 1.17
Antigen-specific memory regulatory CD4+Foxp3+ T cells control memory responses to influenza virus infection. J Immunol (2013) 1.16
Murid herpesvirus 4 strain 68 M2 protein is a B-cell-associated antigen important for latency but not lymphocytosis. J Virol (2003) 1.14
T cell responses to influenza virus infection: effector and memory cells. Viral Immunol (2004) 1.12
Immune control of HSV-1 latency. Viral Immunol (2005) 1.12
Antigen-specific CD8+ T cell clonal expansions develop from memory T cell pools established by acute respiratory virus infections. J Immunol (2007) 1.10